126 related articles for article (PubMed ID: 6428017)
21. Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.
Vishnevsky AS; Shtofmakher JA; Bokhman JV; Tsyrlina EV; Bobrov JF; Chepick OF; Sofroniy DF
Clin Exp Obstet Gynecol; 1990; 17(3-4):159-62. PubMed ID: 2127240
[TBL] [Abstract][Full Text] [Related]
22. [The antiestrogen tamoxifen in advanced breast cancer (author's transl)].
Margreiter R
Langenbecks Arch Chir; 1980; 351(4):249-62. PubMed ID: 6779066
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of the endometrium and hormonal receptors.
Satyaswaroop PG; Zaino RJ; Mortel R
Cancer Treat Res; 1989; 49():71-92. PubMed ID: 2577204
[No Abstract] [Full Text] [Related]
24. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
de Ziegler D; Bergeron C; Cornel C; Medalie DA; Massai MR; Milgrom E; Frydman R; Bouchard P
J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810
[TBL] [Abstract][Full Text] [Related]
25. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Carlson JA; Allegra JC; Day TG; Wittliff JL
Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
[TBL] [Abstract][Full Text] [Related]
27. Hormone receptors in endometrial cancer.
Gurpide E
Cancer; 1981 Jul; 48(2 Suppl):638-41. PubMed ID: 7023668
[TBL] [Abstract][Full Text] [Related]
28. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
[TBL] [Abstract][Full Text] [Related]
29. Endocrine profile associated with estrogen and progesterone receptors in leiomyoma and normal myometrium.
Sadan O; van Iddekinge B; Savage N; van der Walt LA; Zakut H
Gynecol Endocrinol; 1990 Mar; 4(1):33-42. PubMed ID: 2110713
[TBL] [Abstract][Full Text] [Related]
30. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.
Tsolaki M; Grammaticos P; Karanasou C; Balaris V; Kapoukranidou D; Kalpidis I; Petsanis K; Dedousi E
Hell J Nucl Med; 2005; 8(1):39-42. PubMed ID: 15886752
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
Liu J; Chen G; Meng XY; Liu ZH; Dong S
Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
[TBL] [Abstract][Full Text] [Related]
32. Correlation of aromatase activity and steroid receptors in human ovarian carcinoma.
Kühnel R; Delemarre JF; Rao BR; Stolk JG
Anticancer Res; 1986; 6(5):889-92. PubMed ID: 3026234
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
34. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
35. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
[TBL] [Abstract][Full Text] [Related]
36. Hormonal receptors in endometrial neoplasias.
Contreras Ortiz O; Sananes CE
Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
[TBL] [Abstract][Full Text] [Related]
37. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
Sawka CA; Pritchard KI; Paterson AH; Sutherland DJ; Thomson DB; Shelley WE; Myers RE; Mobbs BG; Malkin A; Meakin JW
Cancer Res; 1986 Jun; 46(6):3152-6. PubMed ID: 3084082
[TBL] [Abstract][Full Text] [Related]
38. Hormonal patterns, steroid receptors and morphological pictures of endometrium in hyperstimulated IVF cycles.
Noci I; Borri P; Coccia ME; Criscuoli L; Scarselli G; Messeri G; Paglierani M; Moncini D; Taddei G
Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):215-20. PubMed ID: 9447377
[TBL] [Abstract][Full Text] [Related]
39. The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer.
Yasumura T; Akami T; Mitsuo M; Oka T; Naitoh K; Yamamoto T; Honjyo H; Okada H
Jpn J Surg; 1990 Jul; 20(4):369-75. PubMed ID: 2117682
[TBL] [Abstract][Full Text] [Related]
40. Changes in receptor status after treatment with tamoxifen in endometrial cancer.
Oriana S; Raspagliesi F; Duca PG; Coradini D; Di Re EM; Ragazzi D; Grillo T; Luciani L
Int J Biol Markers; 1988; 3(4):233-6. PubMed ID: 3235850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
